Novo Nordisk A/S B Shares Adrhedged ETF NVOH

$50.61 +1.35 (2.74%)

Valuation

Market cap: —
Revenue TTM: $0
Net income TTM: $0
P/E (trailing): —
P/E (forward): —
Profit margin: 0.00%
Debt to equity: —

Trading

Volume: 247
Avg volume: —
Day's range: $50.56 – $50.61
Shares out: —
Stochastic %K: —
Beta: —
Analysts: —
Price target: —

Price

Company profile

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.

Phone: 908-781-0560

Latest news

No headlines yet.